Influence of Olfacto-gustatory Sensoriality on the Nutritional Status of Patients With Amyotrophic Lateral Sclerosis

Recruiting Observational Study
Amyotrophic Lateral Sclerosis (ALS)
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
60 (estimated)
Sponsor
Centre Hospitalier Universitaire Dijon · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterised by progressive diffuse muscular paralysis due to the inexorable loss of motor neurons in the primary motor cortex, the corticospinal tract, the brain stem and the spinal cord. Over the course of the disease, when the phrenic motor neurons are involved, diaphragmatic weakness develops, leading to restrictive respirato…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: Inclusion criteria\*: * Incident cases of definite or probable ALS according to El-Escorial criteria (3) followed up at the participating regional centre of competence * Patient aged over 18 * Patient fluent in French * Patient having given oral consent Exclusion Criteria: * …
Contacts

Marjolaine GEORGES

0380293772

marjolaine.georges@chu-dijon.fr

CONTACT